Abbott Laboratories buy Barclays PLC
Start price
26.01.24
/
50%
€103.14
Target price
26.01.25
€129.82
Performance (%)
-1.75%
Price
22:26
€100.82
Summary
This prediction is currently active. With a performance of -1.75%, the BUY prediction by Barclays_PLC is trending in the wrong direction. A total of €0.52 was paid as dividends for this prediction. This prediction currently runs until 26.01.25. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Abbott Laboratories | -2.127% | -2.127% |
iShares Core DAX® | 0.936% | 1.535% |
iShares Nasdaq 100 | 3.064% | 1.968% |
iShares Nikkei 225® | 1.898% | -0.295% |
iShares S&P 500 | 1.653% | 2.318% |
Comments by Barclays_PLC for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Barclays PLC from $133.00 to $141.00. They now have an "overweight" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Barclays_PLC for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€100.82
22.04.24
22.04.24
€131.54
22.04.25
22.04.25
0.00%
22:26
22:26